These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8161111)

  • 41. Non-classical Kawasaki disease in a 2 month old infant.
    Hartmann I; Weiss K; Bistritzer T; Baram S; Goldman M
    Isr Med Assoc J; 2006 Aug; 8(8):581-2. PubMed ID: 16958253
    [No Abstract]   [Full Text] [Related]  

  • 42. [A case of atypical Kawasaki disease].
    Biani D; Malandra L; Gaeta G; Rizzo L
    Pediatr Med Chir; 1998; 20(2):155-6. PubMed ID: 9706642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kawasaki disease.
    Bavdekar SB; Vaswani LK; Shalini H; Chandu KV; Gaikwad R; Kamat JR
    J Indian Med Assoc; 1998 Aug; 96(8):257-8. PubMed ID: 9830299
    [No Abstract]   [Full Text] [Related]  

  • 44. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 45. Painful jaundice revealing Kawasaki disease in a young man.
    Granel B; Serratrice J; Ene N; Igual JP; Habib G; Disdier P; Weiller PJ
    J Gastroenterol Hepatol; 2004 Jun; 19(6):713-5. PubMed ID: 15151633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kawasaki disease in older children and adolescents.
    Stockheim JA; Innocentini N; Shulman ST
    J Pediatr; 2000 Aug; 137(2):250-2. PubMed ID: 10931420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kawasaki disease.
    Shulman ST; Bendet M
    Compr Ther; 1997 Jan; 23(1):13-8. PubMed ID: 9067077
    [No Abstract]   [Full Text] [Related]  

  • 49. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
    Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence for superantigen mediated process in Kawasaki disease.
    De Inocencio J; Hirsch R
    Arch Dis Child; 1995 Sep; 73(3):275-6. PubMed ID: 7492179
    [No Abstract]   [Full Text] [Related]  

  • 51. Platelet Activation Dynamics in Kawasaki Disease- Revisited.
    Vignesh P; Singh S
    Indian J Pediatr; 2019 Mar; 86(3):216-217. PubMed ID: 30741390
    [No Abstract]   [Full Text] [Related]  

  • 52. [Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
    Marcinkiewicz J; Szymanowska Z; Mazurek A
    Przegl Lek; 1998; 55(11):611-3. PubMed ID: 10216377
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Kawasaki disease].
    Lebranchu Y
    Ann Dermatol Venereol; 1993; 120(9):587-8. PubMed ID: 8161111
    [No Abstract]   [Full Text] [Related]  

  • 54. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N; Teramura K; Tanaka T
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract]   [Full Text] [Related]  

  • 55. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 56. Lymphocyte abnormalities and complement activation in Kawasaki disease.
    Laxer RM; Schaffer FM; Myones BL; Yount WJ; Rowe RD; Rubin L; Stein LD; Gelfand EW; Silverman ED
    Prog Clin Biol Res; 1987; 250():175-84. PubMed ID: 3423037
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.